1Palazzuoli A, Gallotta M, Quatrini I, et al. Natriuretic peptides (BNP and NT- proBNP ) : measurement and relevance in heart failure[J]. Vasc Health Risk Manag, 2010, 6: 411.
2Vanderheyden M, Vrints C, Verstreken S, et al. B- type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications Biomark [ J ]. Med, 2010, 4(2): 315.
3Kapoun A M, liang F, O'Young G, et al. B2 Type natriuretic peptide exerts broad functional opposition to transforming growth factor -βin primary human cardiac fibroblasts [J]. Circulation Research, 2004, 94(4): 453.
4Veien K T, Jensen J K, Hildebrandt P, et al. Natriuretie peptides as cardiac markers in clinical practice[J]. Ugeskr laeger, 2010, 172(30): 2111.
6Nakagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretie peptide in cardiocyte hypertrophy: evidence for brain natriuretie peptide as an "emergeney"eardieae hormone against ventrieular overload[J]. J Clin Invest, 1995, 96: 1280.
7Maeda K, Tsutamota T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end diastolic pressure in patients with symptomatic left ventricular dysfunction[J]. Am Heart J, 1998, 135: 825.
8Berger R, Huelsman M, Strecker K, et al. B - natriuretic peptide preddicts sudden in patients with chronic hear failure [J]. Circulation, 2002, 105: 2392.
二级参考文献10
1Steen H,,Futterer S,Merten C,et al.Rela-tive role of NT-pro BNP and cardiac troponin T at96hours for estimation of infarct size and left ventricular function after acute myocardial infarction[].Journal of Cardiovascular Magnetic Resonance.2007
2Drewniak W,Snopek G,Zarukiewicz M,et al.Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with a-cute myocardial infarction[].Kardiologia Polska.2008
3Hobbs RE,Mills RM.Endogenous B-type natriuretic peptide:a limb of the regulatory re-sponse to acutely decompensated heart failure[].Clinical Cardiology.2008
4Huntley BK,Sandberg SM,Noser JA,et al.BNP-induced activation of cGMP in humancardiac fibroblasts:interactions with fibronec-tin and natriuretic peptide receptors[].Journal of Cellular Physiology.2006
5Makikallio K,Rounioja S,Vuolteenaho O,et al.Fetal cardiac natriuretic peptide ex-pression and cardiovascular hemodynamics in endotoxin-induced acute cardiac dysfunction in mouse[].Pediatric Research.2006
6ChiurchiùV,Izzi V,D′Aquilio F,et al.Brain Natriuretic Peptide(BNP)regulates the production of inflammatory mediators in human THP-1macrophages[].Regulatory Peptides.2008
7Ikeda K,Tojo K,Udagawa T,et al.Cellu-lar physiology of rat cardiac myocytes in cardi-ac fibrosis:in vitro simulation using the car-diac myocyte/cardiac non-myocyte co-cul-ture system[].Hypertension Research.2008
8Hori Y,Tsubaki M,Katou A,et al.Eval-uation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis[].Journal of Veterinary Internal Medicine.2008
9Milting H,Ellinghaus P,Seewald M,et al.Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices[].The Journal of Heart and Lung Transplantation.2008
10Vorovich EE,Chuai S,Li M,et al.Com-parison of matrixmetalloproteinase9and brain natriuretic peptide as clinical biomarkers in chronic heart failure[].American Heart Journal.2008
7Serebruany V,Matinin A,Qiu FH,et al. Selective thromboxane in-hibition after vascular protectant AGI - 1067 : Result of assessmentof lipoprotein profiles( ALPS) biomarkers in vitro and in vivo sub-study [J]. Thromb Thrombolysis,2008 ,36(3) :583 - 589.
8Celinski R, Grzywa-Celinska A, Cholewinski W, et al. Relationshipb-etween plasma brain natriuretic peptide level and left ventricularsystolic function in coronary artery disease [ J ]. Pol Merkur Lek-arshi,2005,18(105) :291 -294.
9Menon SG, Mills RM, Schellenberger U, et al. Clinical implications ofdefective B - type natriuretic peptide [ J ]. Clin Cardlol, 2009,32 : 36 -41.
